CARECLOUD INC - CCLD 8 3/4 PERP (CCLDO) Stock Fundamental Analysis
USA - NASDAQ:CCLDO - US14167R3084
20.9466 USD
-0.39 (-1.82%)
CCLDO gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 35 industry peers in the Health Care Technology industry. CCLDO has an excellent financial health rating, but there are some minor concerns on its profitability. CCLDO is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
CCLDO had negative earnings in the past year.
CCLDO had a positive operating cash flow in the past year.
In the past 5 years CCLDO always reported negative net income.
CCLDO had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
Looking at the Return On Assets, with a value of 0.02%, CCLDO is in the better half of the industry, outperforming 80.00% of the companies in the same industry.
The Return On Equity of CCLDO (0.02%) is better than 80.00% of its industry peers.
Looking at the Return On Invested Capital, with a value of 16.12%, CCLDO belongs to the top of the industry, outperforming 94.29% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.02% | ||
| ROE | 0.02% | ||
| ROIC | 16.12% |
ROA(3y)-32.11%
ROA(5y)-24.15%
ROE(3y)-57.71%
ROE(5y)-41.4%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
CCLDO has a better Profit Margin (0.01%) than 80.00% of its industry peers.
The Operating Margin of CCLDO (10.77%) is better than 85.71% of its industry peers.
CCLDO's Operating Margin has improved in the last couple of years.
With a Gross Margin value of 46.00%, CCLDO is not doing good in the industry: 68.57% of the companies in the same industry are doing better.
CCLDO's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 10.77% | ||
| PM (TTM) | 0.01% | ||
| GM | 46% |
OM growth 3Y59.79%
OM growth 5Y95.05%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.11%
GM growth 5Y4.51%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so CCLDO is still creating some value.
Compared to 1 year ago, CCLDO has more shares outstanding
The number of shares outstanding for CCLDO has been increased compared to 5 years ago.
Compared to 1 year ago, CCLDO has an improved debt to assets ratio.
2.2 Solvency
An Altman-Z score of 29.36 indicates that CCLDO is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 29.36, CCLDO belongs to the top of the industry, outperforming 97.14% of the companies in the same industry.
The Debt to FCF ratio of CCLDO is 0.02, which is an excellent value as it means it would take CCLDO, only 0.02 years of fcf income to pay off all of its debts.
With an excellent Debt to FCF ratio value of 0.02, CCLDO belongs to the best of the industry, outperforming 82.86% of the companies in the same industry.
CCLDO has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.00, CCLDO is in the better half of the industry, outperforming 65.71% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0.02 | ||
| Altman-Z | 29.36 |
ROIC/WACC1.64
WACC9.82%
2.3 Liquidity
A Current Ratio of 1.91 indicates that CCLDO should not have too much problems paying its short term obligations.
CCLDO has a Current ratio of 1.91. This is comparable to the rest of the industry: CCLDO outperforms 42.86% of its industry peers.
A Quick Ratio of 1.88 indicates that CCLDO should not have too much problems paying its short term obligations.
With a Quick ratio value of 1.88, CCLDO perfoms like the industry average, outperforming 42.86% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.91 | ||
| Quick Ratio | 1.88 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 95.70% over the past year.
CCLDO shows a small growth in Revenue. In the last year, the Revenue has grown by 0.04%.
CCLDO shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 11.47% yearly.
EPS 1Y (TTM)95.7%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%128.57%
Revenue 1Y (TTM)0.04%
Revenue growth 3Y-7.4%
Revenue growth 5Y11.47%
Sales Q2Q%-2.54%
3.2 Future
CCLDO is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 66.79% yearly.
Based on estimates for the next years, CCLDO will show a quite strong growth in Revenue. The Revenue will grow by 8.54% on average per year.
EPS Next Y140.8%
EPS Next 2Y66.79%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year3.58%
Revenue Next 2Y8.54%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for CCLDO. In the last year negative earnings were reported.
Based on the Price/Forward Earnings ratio of 133.93, the valuation of CCLDO can be described as expensive.
CCLDO's Price/Forward Earnings ratio is in line with the industry average.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.13, CCLDO is valued quite expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 133.93 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CCLDO indicates a somewhat cheap valuation: CCLDO is cheaper than 65.71% of the companies listed in the same industry.
CCLDO's Price/Free Cash Flow is on the same level as the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 50.91 | ||
| EV/EBITDA | 35.36 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as CCLDO's earnings are expected to grow with 66.79% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y66.79%
EPS Next 3YN/A
5. Dividend
5.1 Amount
CCLDO has a Yearly Dividend Yield of 7.67%, which is a nice return.
CCLDO's Dividend Yield is rather good when compared to the industry average which is at 4.49. CCLDO pays more dividend than 97.14% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.41, CCLDO pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 7.67% |
5.2 History
The dividend of CCLDO is nicely growing with an annual growth rate of 21.20%!
CCLDO has paid a dividend for less than 5 years, so there is no long track record yet.
Dividend Growth(5Y)21.2%
Div Incr Years1
Div Non Decr Years1
5.3 Sustainability
CCLDO's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DPN/A
EPS Next 2Y66.79%
EPS Next 3YN/A
CARECLOUD INC - CCLD 8 3/4 PERP
NASDAQ:CCLDO (9/30/2025, 12:32:01 PM)
20.9466
-0.39 (-1.82%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners19.86%
Inst Owner ChangeN/A
Ins Owners14.48%
Ins Owner ChangeN/A
Market Cap886.46M
Analysts80
Price Target27.73 (32.38%)
Short Float %0.01%
Short Ratio0.26
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 7.67% |
Yearly Dividend0.92
Dividend Growth(5Y)21.2%
DPN/A
Div Incr Years1
Div Non Decr Years1
Ex-Date
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)58.82%
Min EPS beat(2)21.57%
Max EPS beat(2)96.08%
EPS beat(4)4
Avg EPS beat(4)72.28%
Min EPS beat(4)21.57%
Max EPS beat(4)100%
EPS beat(8)5
Avg EPS beat(8)-0.12%
EPS beat(12)8
Avg EPS beat(12)-1.47%
EPS beat(16)12
Avg EPS beat(16)11.57%
Revenue beat(2)1
Avg Revenue beat(2)2.17%
Min Revenue beat(2)-1.27%
Max Revenue beat(2)5.6%
Revenue beat(4)1
Avg Revenue beat(4)0.34%
Min Revenue beat(4)-1.89%
Max Revenue beat(4)5.6%
Revenue beat(8)1
Avg Revenue beat(8)-2.29%
Revenue beat(12)1
Avg Revenue beat(12)-3.19%
Revenue beat(16)3
Avg Revenue beat(16)-2.21%
PT rev (1m)-5.98%
PT rev (3m)-19.21%
EPS NQ rev (1m)-18.19%
EPS NQ rev (3m)-35.72%
EPS NY rev (1m)-22.58%
EPS NY rev (3m)-20%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.21%
Revenue NY rev (1m)3.14%
Revenue NY rev (3m)2.61%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 133.93 | ||
| P/S | 7.93 | ||
| P/FCF | 50.91 | ||
| P/OCF | 35.73 | ||
| P/B | 15.81 | ||
| P/tB | 41.48 | ||
| EV/EBITDA | 35.36 |
EPS(TTM)-0.04
EYN/A
EPS(NY)0.16
Fwd EY0.75%
FCF(TTM)0.41
FCFY1.96%
OCF(TTM)0.59
OCFY2.8%
SpS2.64
BVpS1.33
TBVpS0.51
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.02% | ||
| ROE | 0.02% | ||
| ROCE | 20.4% | ||
| ROIC | 16.12% | ||
| ROICexc | 16.12% | ||
| ROICexgc | 39.14% | ||
| OM | 10.77% | ||
| PM (TTM) | 0.01% | ||
| GM | 46% | ||
| FCFM | 15.58% |
ROA(3y)-32.11%
ROA(5y)-24.15%
ROE(3y)-57.71%
ROE(5y)-41.4%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y52.71%
ROICexcg growth 5Y104.32%
ROICexc growth 3Y91.65%
ROICexc growth 5Y92.03%
OM growth 3Y59.79%
OM growth 5Y95.05%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.11%
GM growth 5Y4.51%
F-Score7
Asset Turnover1.49
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0.02 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 54.79% | ||
| Cap/Sales | 6.62% | ||
| Interest Coverage | 63.03 | ||
| Cash Conversion | 97.14% | ||
| Profit Quality | 124386% | ||
| Current Ratio | 1.91 | ||
| Quick Ratio | 1.88 | ||
| Altman-Z | 29.36 |
F-Score7
WACC9.82%
ROIC/WACC1.64
Cap/Depr(3y)74.91%
Cap/Depr(5y)76.9%
Cap/Sales(3y)8.36%
Cap/Sales(5y)8%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)95.7%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%128.57%
EPS Next Y140.8%
EPS Next 2Y66.79%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)0.04%
Revenue growth 3Y-7.4%
Revenue growth 5Y11.47%
Sales Q2Q%-2.54%
Revenue Next Year3.58%
Revenue Next 2Y8.54%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y15735.1%
EBIT growth 3Y47.96%
EBIT growth 5Y117.42%
EBIT Next Year209.54%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y112.11%
FCF growth 3Y68.43%
FCF growth 5Y21.21%
OCF growth 1Y21.45%
OCF growth 3Y15.69%
OCF growth 5Y22.06%